Mark L. Portnoy insider trades: Cryo Cell International (CCEL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 24, 2020 | CCEL | ↑ Buy | 5,000 | $8.25 | $41K | Direct | Jul 28, 2020 (4d) |
| Jul 24, 2020 | CCEL | ↑ Buy | 4,000 | $8.25 | $33K | By 401K | Jul 28, 2020 (4d) |
| Jul 20, 2020 | CCEL | ↑ Buy | 1,881 | $7.97 | $15K | By 401K | Jul 20, 2020 (0d) |
| Jul 13, 2020 | CCEL | ↑ Buy | 200 | $7.51 | $2K | Direct | Jul 15, 2020 (2d) |
| Jun 15, 2020 | CCEL | ↑ Buy | 18,130 | $7.77 | $141K | By 401K | Jun 16, 2020 (1d) |
| Jun 5, 2020 | CBAI | ↓ Sell | 1,760,089 | $0.01 | $13K | Direct | Jun 8, 2020 (3d) |
| Jun 1, 2020 | CBAI | ↓ Sell | 1,628,065 | $0.01 | $12K | Direct | Jun 2, 2020 (1d) |
| May 7, 2020 | CBAI | ↓ Sell | 2,236,574 | $0.01 | $17K | Direct | May 14, 2020 (7d) |
| May 5, 2020 | CBAI | ↓ Sell | 779,138 | $0.01 | $6K | Direct | May 14, 2020 (9d) |
| May 5, 2020 | CBAI | ↓ Sell | 945,955 | $0.01 | $7K | Direct | May 6, 2020 (1d) |
| May 5, 2020 | CBAI | ↓ Sell | 38,333 | $0.01 | $287 | Direct | May 6, 2020 (1d) |
| May 1, 2020 | CBAI | ↓ Sell | 5,183,546 | $0.01 | $40K | Direct | May 4, 2020 (3d) |
| Apr 29, 2020 | CBAI | ↓ Sell | 816,454 | $0.01 | $6K | Direct | Apr 30, 2020 (1d) |
| Feb 20, 2020 | CBAI | ↓ Sell | 5,000,000 | $0.01 | $43K | Direct | Feb 21, 2020 (1d) |
| Feb 12, 2020 | CBAI | ↓ Sell | 5,313,710 | $0.01 | $44K | Direct | Feb 13, 2020 (1d) |
| Feb 3, 2020 | CBAI | ↓ Sell | 361,290 | $0.01 | $3K | Direct | Feb 5, 2020 (2d) |
| Jan 31, 2020 | CBAI | ↓ Sell | 4,000,000 | $0.01 | $32K | Direct | Feb 3, 2020 (3d) |
| Jan 29, 2020 | CBAI | ↓ Sell | 1,000,000 | $0.01 | $8K | Direct | Jan 30, 2020 (1d) |
| Jan 7, 2020 | CBAI | ↓ Sell | 1,000,000 | $0.01 | $8K | Direct | Jan 7, 2020 (0d) |
| Nov 21, 2019 | CCEL | ↓ Sell | 134,977 | $3.39 | $457K | Direct | Nov 25, 2019 (4d) |
| Nov 15, 2019 | CBAI | ↓ Sell | 1,478,622 | $0.01 | $12K | Direct | Nov 19, 2019 (4d) |
| Sep 19, 2019 | CCEL | ↓ Sell | 20,000 | $7.54 | $151K | by partnership | Sep 20, 2019 (1d) |
| Sep 19, 2019 | CCEL | ↑ Buy | 20,000 | $7.54 | $151K | Direct | Sep 20, 2019 (1d) |
| Aug 16, 2018 | CBAI | ↓ Sell | 5,000,000 | $0.01 | $31K | Direct | Aug 17, 2018 (1d) |
| Feb 26, 2018 | CBAI | ↑ Buy | 1,206,705 | $0.00 | $5K | Direct | Feb 26, 2018 (0d) |
| Dec 28, 2017 | CCEL | ↓ Sell | 10,500 | $9.36 | $98K | by partnership | Dec 29, 2017 (1d) |
| May 19, 2017 | CCEL | ↓ Sell | 18,000 | $5.00 | $90K | by partnership | May 23, 2017 (4d) |
| May 19, 2017 | CCEL | ↑ Buy | 6,000 | $5.00 | $30K | Direct | May 23, 2017 (4d) |
| Sep 22, 2015 | CCEL | ↑ Buy | 10,000 | $3.42 | $34K | Direct | Sep 24, 2015 (2d) |
| Sep 22, 2015 | CCEL | ↓ Sell | 10,000 | $3.42 | $34K | by partnership | Sep 24, 2015 (2d) |
| Jul 15, 2014 | CCEL | ↑ Buy | 3,600 | $2.30 | $8K | By 401K | Jul 17, 2014 (2d) |
| Jul 10, 2014 | CCEL | ↑ Buy | 240 | $2.30 | $552 | By 401K | Jul 14, 2014 (4d) |
| Jun 2, 2014 | CCEL | ↑ Buy | 1,100 | $2.30 | $3K | By 401K | Jun 3, 2014 (1d) |
| Jul 31, 2013 | CCEL | ↑ Buy | 660 | $1.82 | $1K | By 401K | Aug 2, 2013 (2d) |
| Jul 23, 2013 | CCEL | ↑ Buy | 3,000 | $1.95 | $6K | By 401K | Jul 24, 2013 (1d) |
| Mar 15, 2013 | CCEL | ↑ Buy | 3,000 | $2.00 | $6K | By 401K | Mar 18, 2013 (3d) |
| Mar 8, 2013 | CCEL | ↑ Buy | 4,000 | $2.03 | $8K | By 401K | Mar 12, 2013 (4d) |
| Jan 9, 2013 | CCEL | ↑ Buy | 2,455 | $2.06 | $5K | By 401K | Jan 9, 2013 (0d) |
| Oct 23, 2012 | CCEL | ↑ Buy | 5,000 | $2.29 | $11K | Direct | Oct 23, 2012 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark L. Portnoy's insider trades
Mark L. Portnoy is Co-CEO at Cryo Cell International (CCEL). Since Oct 23, 2012, Mark has reported 18 open-market purchases worth $501K and 21 sales worth $1.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), option exercises (3 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CCEL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.